Published online February 26, 2007
doi:10.1084/jem.20061792
The Journal of Experimental Medicine, Vol. 204, No. 3, 595-603
The Rockefeller University Press, 0022-1007 $30.00
© 2007 Zhu et al.
Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation
Jia Zhu1,6,
David M. Koelle1,2,4,6,9,
Jianhong Cao7,
Julio Vazquez8,
Meei Li Huang1,6,
Florian Hladik2,5,6,
Anna Wald1,2,3,6, and
Lawrence Corey1,2,4,6
1 Department of Laboratory Medicine, 2 Department of Medicine, 3 Department of Epidemiology, 4 Department of Pathobiology, and 5 Department of Obstetrics and Gynecology, University of Washington, Seattle, WA 98195
6 Infectious Diseases Program, 7 Immune Monitoring Lab, and 8 Scientific Imaging, Fred Hutchinson Cancer Research Center, Seattle, WA 98109
9 Benaroya Research Institute, Seattle, WA 98104
CORRESPONDENCE Lawrence Corey: lcorey{at}u.washington.edu
Cytotoxic CD8+ T cells play a critical role in controlling herpes simplex virus (HSV) infection and reactivation. However, little is known about the spatiotemporal dynamics of CD8+ T cells during HSV lesion evolution or about their involvement in immune surveillance after lesion resolution. Using quantum dotconjugated peptidemajor histocompatibility complex multimers, we investigated the in vivo localization of HSV-2specific CD8+ T cells in sequential biopsies of human genital skin during acute, resolving, and healed stages of HSV-2 reactivation. Our studies revealed that functionally active CD8+ T cells selectively infiltrated to the site of viral reactivation. After lesion healing in concert with complete reepithelialization and loss of HSV DNA from skin biopsies, HSV-2specific CD8+ T cells persisted for more than two months at the dermalepidermal junction, adjacent to peripheral nerve endings. In two out of the six sequentially studied individuals, HSV-2 DNA reappeared in clinically and histologically normalappearing skin. Detection of viral DNA was accompanied by increased numbers of both HSV-specific and total CD8+ T cells in the dermis. These findings indicate that the frequency and clinical course of HSV-2 reactivation in humans is influenced by virus-specific CD8+ T cells that persist in peripheral mucosa and genital skin after resolution of herpes lesions.
Abbreviations used: NCAM, neural cell adhesion molecule; Qdot, quantum dot; Qdot multimer, Qdot-conjugated peptideMHC multimer.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Jerome, K. R.
(2008). Viral Modulation of T-Cell Receptor Signaling. J. Virol.
82: 4194-4204
[Full Text]
-
Koelle, D. M., Magaret, A., McClurkan, C. L., Remington, M. L., Warren, T., Teofilovici, F., Wald, A.
(2008). Phase I Dose-Escalation Study of a Monovalent Heat Shock Protein 70-Herpes Simplex Virus Type 2 (HSV-2) Peptide-Based Vaccine Designed To Prime or Boost CD8 T-Cell Responses in HSV-Naive and HSV-2-Infected Subjects. CVI
15: 773-782
[Abstract]
[Full Text]
-
Peng, T., Zhu, J., Hwangbo, Y., Corey, L., Bumgarner, R. E.
(2008). Independent and Cooperative Antiviral Actions of Beta Interferon and Gamma Interferon against Herpes Simplex Virus Replication in Primary Human Fibroblasts. J. Virol.
82: 1934-1945
[Abstract]
[Full Text]